After selection to obtain mRNA technology: Egypt seeks to produce AstraZeneca vaccine

CAIRO – 24 February 2022: The Ministry of Health and Population is drafting a proposal to produce AstraZeneca anti-COVID-19 vaccine locally through VACSERA, which already produces Sinovac doses.

That is in light of Egypt's selection as one of the recipients of the mRNA technology used in the manufacturing of vaccines and other important medical drugs to confront many incurable diseases.

Higher Education Minister and Acting Health Minister Khaled Abdel Ghaffar announced Sunday that Egypt produced over 30 million doses of the effective and safe Sinovac/VACSERA COVID-19 vaccine.

Egyptian Minister of Higher Education and Acting Minister of Health and Population Khaled Abdel Ghaffar met last week with AstraZeneca regional director for the Middle East and Africa, Belin Inciso to discuss cooperation in the transfer of vaccine manufacturing technology.